Each program runs on the same integrated infrastructure and the same accredited lab, so health plans can consolidate multiple screening gaps under a single accountable partner.
At-home HPV self-collection using the FDA-approved BD Onclarity assay via Waters Corporation. Detects 14 high-risk HPV genotypes, reporting 6 individually plus pooled groups with extended genotyping, confirmed by NCQA to close CCS at home or in clinic.
See the full cervical program →
At-home fecal immunochemical testing detects hidden blood in the stool, a key early indicator of colorectal cancer. Simple, non-invasive, and completed at home.
At-home HbA1c measures average blood sugar over roughly three months, a triple-weighted measure in Medicare Advantage Star Ratings.
At-home eGFR and uACR testing supports the Kidney Health Evaluation for patients with diabetes, catching kidney disease earlier.
Our high-complexity lab also supports molecular and PCR diagnostics, including women's health and infectious disease panels.
Engagement, kits, logistics, lab, and reporting under one roof, instead of four or five vendors.
Consistent, real-time reporting and HEDIS supplemental data files across every measure.
Every program processed in our own high-complexity CLIA and COLA accredited laboratory.
Talk to us about consolidating your screening programs on one integrated platform.
The information on this page is provided for general informational purposes for health plans, employers, providers, and partners. It is not medical advice and is not a substitute for diagnosis, treatment, or the judgment of a qualified healthcare professional. Individuals should discuss screening decisions with their own healthcare provider.
Program results described on this site reflect specific engagements and are not a guarantee or prediction of results any other organization will achieve. Outcomes vary with population, program design, and other factors. Program, test, and service availability varies by state, health plan, and member eligibility, and descriptions are subject to change.
HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA). All other trademarks are the property of their respective owners and are used for identification purposes only. Reference to a third-party product, partner, or organization does not imply its endorsement of SNT Biotech.